{
    "organizations": [],
    "uuid": "cef901df224a4d8896467a49480e2f251acea835",
    "author": "",
    "url": "https://www.reuters.com/article/brief-synlogic-progresses-clinical-and-p/brief-synlogic-progresses-clinical-and-preclinical-pipeline-and-outlines-2018-catalysts-idUSFWN1P00DM",
    "ord_in_thread": 0,
    "title": "BRIEF-Synlogic Progresses Clinical And Preclinical Pipeline And Outlines 2018 Catalysts",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 5, 2018 / 1:20 PM / Updated 4 minutes ago BRIEF-Synlogic Progresses Clinical And Preclinical Pipeline And Outlines 2018 Catalysts Reuters Staff \nJan 5 (Reuters) - Synlogic Inc: \n* SYNLOGIC PROGRESSES CLINICAL AND PRECLINICAL PIPELINE AND OUTLINES 2018 CATALYSTS \n* SYNLOGIC - EXPECTS TO PRESENT FULL CLINICAL DATA FROM FIRST IN-HUMAN STUDY OF SYNTHETIC BIOTIC MEDICINE EXPECTED IN Q1 2018 \n* SYNLOGIC INC - IND FOR SYNB1020 FOR TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH LIVER DISEASE HAS BEEN CLEARED BY FDA \n* SYNLOGIC INC - ADDITIONAL TRIALS IN PATIENTS WITH UCD AND PKU EXPECTED TO BEGIN IN 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-01-05T15:19:00.000+02:00",
    "crawled": "2018-01-05T15:36:38.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "progress",
        "clinical",
        "preclinical",
        "pipeline",
        "outline",
        "catalyst",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "synlogic",
        "inc",
        "synlogic",
        "progress",
        "clinical",
        "preclinical",
        "pipeline",
        "outline",
        "catalyst",
        "synlogic",
        "expects",
        "present",
        "full",
        "clinical",
        "data",
        "first",
        "study",
        "synthetic",
        "biotic",
        "medicine",
        "expected",
        "q1",
        "synlogic",
        "inc",
        "ind",
        "synb1020",
        "treatment",
        "hyperammonemia",
        "patient",
        "liver",
        "disease",
        "cleared",
        "fda",
        "synlogic",
        "inc",
        "additional",
        "trial",
        "patient",
        "ucd",
        "pku",
        "expected",
        "begin",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}